Literature DB >> 9097958

Linkage and physical mapping of X-linked lissencephaly/SBH (XLIS): a gene causing neuronal migration defects in human brain.

M E Ross1, K M Allen, A K Srivastava, T Featherstone, J G Gleeson, B Hirsch, B N Harding, E Andermann, R Abdullah, M Berg, D Czapansky-Bielman, D J Flanders, R Guerrini, J Motté, A P Mira, I Scheffer, S Berkovic, F Scaravilli, R A King, D H Ledbetter, D Schlessinger, W B Dobyns, C A Walsh.   

Abstract

While disorders of neuronal migration are associated with as much as 25% of recurrent childhood seizures, few of the genes required to establish neuronal position in cerebral cortex are known. Subcortical band heterotopia (SBH) and lissencephaly (LIS), two distinct neuronal migration disorders producing epilepsy and variable cognitive impairment, can be inherited alone or together in a single pedigree. Here we report a new genetic locus, XLIS, mapped by linkage analysis of five families and physical mapping of a balanced X;2 translocation in a girl with LIS. Linkage places the critical region in Xq21-q24, containing the breakpoint that maps to Xq22.3-q23 by high-resolution chromosome analysis. Markers used for somatic cell hybrid and fluorescence in situ hybridization analyses place the XLIS region within a 1 cM interval. These data suggest that SBH and X-linked lissencephaly are caused by mutation of a single gene, XLIS, that the milder SBH phenotype in females results from random X-inactivation (Lyonization), and that cloning of genes from the breakpoint region on X will yield XLIS.

Entities:  

Mesh:

Year:  1997        PMID: 9097958     DOI: 10.1093/hmg/6.4.555

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  14 in total

1.  Cortical dysplasia: a possible substrate for brain tumors.

Authors:  Shiyong Liu; Chunqing Zhang; Haifeng Shu; Didier Wion; Hui Yang
Journal:  Future Oncol       Date:  2012-03       Impact factor: 3.404

Review 2.  Balanced translocations in mental retardation.

Authors:  Geert Vandeweyer; R Frank Kooy
Journal:  Hum Genet       Date:  2009-04-05       Impact factor: 4.132

3.  High expression of doublecortin and KIAA0369 protein in fetal brain suggests their specific role in neuronal migration.

Authors:  M Mizuguchi; J Qin; M Yamada; K Ikeda; S Takashima
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

Review 4.  Advanced microscopic imaging methods to investigate cortical development and the etiology of mental retardation.

Authors:  Tarik F Haydar
Journal:  Ment Retard Dev Disabil Res Rev       Date:  2005

Review 5.  The unfolding story of two lissencephaly genes and brain development.

Authors:  O Reiner
Journal:  Mol Neurobiol       Date:  1999 Oct-Dec       Impact factor: 5.590

6.  Birthdate and cell marker analysis of scrambler: a novel mutation affecting cortical development with a reeler-like phenotype.

Authors:  J L González; C J Russo; D Goldowitz; H O Sweet; M T Davisson; C A Walsh
Journal:  J Neurosci       Date:  1997-12-01       Impact factor: 6.167

Review 7.  Genetic basis in epilepsies caused by malformations of cortical development and in those with structurally normal brain.

Authors:  Danielle M Andrade
Journal:  Hum Genet       Date:  2009-06-18       Impact factor: 4.132

8.  Heterotopic neurogenesis in a rat with cortical heterotopia.

Authors:  K S Lee; J L Collins; M J Anzivino; E A Frankel; F Schottler
Journal:  J Neurosci       Date:  1998-11-15       Impact factor: 6.167

9.  Dedicator of cytokinesis 8 is disrupted in two patients with mental retardation and developmental disabilities.

Authors:  Bradley L Griggs; Sydney Ladd; Robert A Saul; Barbara R DuPont; Anand K Srivastava
Journal:  Genomics       Date:  2007-12-03       Impact factor: 5.736

10.  Isolation of BAC clones spanning the Xq22.3 translocation breakpoint in a lissencephaly patient with a de novo X;2 translocation.

Authors:  N Matsumoto; D T Pilz; J A Fantes; K Kittikamron; D H Ledbetter
Journal:  J Med Genet       Date:  1998-10       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.